Cited by 325Streptococcal Infections and TreatmentsInfective Endocarditis Diagnosis and ManagementVenous Thromboembolism Diagnosis and Management

The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.

Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease

Open access

Szekely, P.·1964·BMJ

DOI 10.1136/bmj.1.5392.1209PMC PMC1814317

Open this paper in CoChat — free account Open PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/bmj.1.5392.1209

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diseases of the Heart and Circulation
M, M. B. (1957) · Postgraduate Medical Journal · doi:10.1136/pgmj.33.377.147 · Cited by 799
An Appreciation of Mitral Stenosis--I
Wood, P. (1954) · BMJ · doi:10.1136/bmj.1.4870.1051 · Cited by 462
THE COURSE OF MITRAL STENOSIS WITHOUT SURGERY: TEN- AND TWENTY-YEAR PERSPECTIVES
Rowe, J., Bland, E. F., Sprague, H. B., & WHITE, P. D. (1960) · Annals of Internal Medicine · doi:10.7326/0003-4819-52-4-741 · Cited by 281
Systemic arterial embolism in rheumatic heart disease
Daley, R., Mattingly, T. W., Holt, C. L., Bland, E. F., & WHITE, P. D. (1951) · American Heart Journal · doi:10.1016/0002-8703(51)90152-4 · Cited by 245
The Regulation of Human Respiration
CUNNINGHAM, D. J. C., & Landmesser, C. M. (1963) · Anesthesiology · doi:10.1097/00000542-196311000-00043 · Cited by 153
Isolation of a Reovirus from a Case of Burkitt's Lymphoma
Bell, T., Massie, A., ROSS, M. G. R., & Williams, M. (1964) · BMJ · doi:10.1136/bmj.1.5392.1212 · Cited by 79
Systemic Embolism and Left Auricular Thrombosis in Relation to Mitral Valvotomy
Belcher, J., & Somerville, W. (1955) · BMJ · doi:10.1136/bmj.2.4946.1000 · Cited by 78
The Regulation of Human Respiration
Cotes, J. E. (1964) · Occupational and Environmental Medicine · doi:10.1136/oem.21.1.82 · Cited by 78
Arterial embolization in relation to mitral valvuloplasty
Ellis, L. B., & Harken, D. E. (1961) · American Heart Journal · doi:10.1016/0002-8703(61)90369-6 · Cited by 63
PROPHYLAXIS OF RECURRENT EMBOLISM OF INTRACARDIAC ORIGIN
Cosgriff, S. W. (1950) · JAMA · doi:10.1001/jama.1950.02910450010003 · Cited by 59

Show all 27 references

Sorted by citations

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,930
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,145
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H. M., Krieger, E. V., Mack, M. J., McLeod, C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 2,110
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Stroke · doi:10.1161/01.str.0000199147.30016.74 · Cited by 1,873
PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION
Petersen, P., GODTFREDSEN, J., Boysen, G., Andersen, E. D., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,814
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O'Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.537 · Cited by 1,642
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
Furie, K. L., Kasner, S. E., Adams, R. J., Albers, G. W., Bush, R. L., Fagan, S. C., Halperin, J. L., Johnston, S. C., Katzan, I. L., Kernan, W. N., et al. (2010) · Stroke · doi:10.1161/str.0b013e3181f7d043 · Cited by 1,497
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000029 · Cited by 2,566
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H. M., Krieger, E. V., Mack, M. J., McLeod, C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.035 · Cited by 1,119
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.05.014 · Cited by 997
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · CHEST Journal · doi:10.1378/chest.08-0678 · Cited by 758
Relation between echocardiographically determined left atrial size and atrial fibrillation.
Henry, W. L., Morganroth, J., Pearlman, A. S., Clark, C. E., Redwood, D. R., Itscoitz, S. B., & Epstein, S. E. (1976) · Circulation · doi:10.1161/01.cir.53.2.273 · Cited by 641
“Of the patients with asymmetric septal hypertrophy who embolized, nine of 11 (82%) at the time of echocardiographic study would have been classified by history as having either chronic (7) or paroxysmal (2) atrial fibrillation.”
Background
Antithrombotic and Thrombolytic Therapy for Valvular Disease
Whitlock, R. P., Sun, J. C. J., Fremes, S. E., Rubens, F. D., & Teoh, K. (2012) · CHEST Journal · doi:10.1378/chest.11-2305 · Cited by 623
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Go, A. S., Halperin, J. L., & Manning, W. J. (2004) · CHEST Journal · doi:10.1378/chest.126.3_suppl.429s · Cited by 547
The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation
Bjerkelund, C. J., & Orning, O. M. (1969) · The American Journal of Cardiology · doi:10.1016/0002-9149(69)90068-x · Cited by 447
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
Hobbs, F., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., Bryan, S., Raftery, J., Davies, M., & Lip, G. (2005) · Health Technology Assessment · doi:10.3310/hta9400 · Cited by 437
Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic
Salem, D. N., Stein, P. D., Al‐Ahmad, A., Bussey, H. I., Horstkotte, D., Houston-Miller, N., & Pauker, S. G. (2004) · CHEST Journal · doi:10.1378/chest.126.3_suppl.457s · Cited by 374
Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)
Husted, S., Wallentin, L. C., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0403 · Cited by 366
Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
Husted, S., Wallentin, L. C., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0443 · Cited by 373
“This situation, of which mitral stenosis is the landmark, is thought to carry the greatest risk of systemic thromboembolism of any common form of acquired native valvular disease, even in the absence of AF, although such estimates are based on old literature (159).”
Background
Management of Atrial Fibrillation
Wood, A. J. J., & Pritchett, E. L. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261906 · Cited by 322
Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group.
(1983) · Stroke · doi:10.1161/01.str.14.5.668 · Cited by 300
“A-6 c 60M N V A F 150/100 yes M 32 35 no H (9) —”
Systemic embolism in mitral valve disease.
Coulshed, N., Epstein, E. J., McKendrick, C. S., Galloway, R. W., & Walker, E. (1970) · Heart · doi:10.1136/hrt.32.1.26 · Cited by 301
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
Veitch, A., Vanbiervliet, G., Gershlick, A., Boustière, C., Baglin, T. P., Smith, L., Radaelli, F., Knight, E., Gralnek, I. M., Hassan, C., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311110 · Cited by 302
New Evidence for Stroke Prevention
Straus, S. E., Majumdar, S. R., & McAlister, F. A. (2002) · JAMA · doi:10.1001/jama.288.11.1388 · Cited by 298
“Antiplatelet therapy Aspirin 28 (19-36) 77 (9.”
BackgroundInfluential
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279
Antithrombotic Therapy in Atrial Fibrillation
DUNN, M. I., Alexander, J. K., de Silva, R., & Hildner, F. J. (1989) · CHEST Journal · doi:10.1378/chest.95.2_supplement.118s · Cited by 270
Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group.
(1984) · Stroke · doi:10.1161/01.str.15.5.779 · Cited by 264
Care of Patients Receiving Long-Term Anticoagulant Therapy
Schulman, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp025373 · Cited by 243
Influence of etiology of atrial fibrillation on incidence of systemic embolism
Hinton, R. C., Kistler, J. P., Fallon, J. T., Friedlich, A. L., & Fisher, C. M. (1977) · The American Journal of Cardiology · doi:10.1016/0002-9149(77)90064-9 · Cited by 247
Valvular and Structural Heart Disease
Salem, D. N., O’Gara, P. T., Madias, C. A., & Pauker, S. G. (2008) · CHEST Journal · doi:10.1378/chest.08-0724 · Cited by 239
2020 Clinical guidelines for Atrial fibrillation and atrial flutter
Arakelyan, M. S., Bockeria, L. A., Vasilieva, E., Sp, G., Golukhova, E. Z., Gorev, M. V., Davtyan, K. V., Drapkina, O. M., Станиславовна, К. Е., Kuchinskaya, Е. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4594 · Cited by 258
ATRIAL FIBRILLATION
Åberg, H. E. (1969) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1969.tb07351.x · Cited by 226
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
Veitch, A., Vanbiervliet, G., Gershlick, A., Boustière, C., Baglin, T. P., Smith, L., Radaelli, F., Knight, E., Gralnek, I. M., Hassan, C., et al. (2016) · Endoscopy · doi:10.1055/s-0042-102652 · Cited by 224
Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures
Veitch, A., Baglin, T. P., Gershlick, A., Harnden, S. M., Tighe, R., & Cairns, S. R. (2008) · Gut · doi:10.1136/gut.2007.142497 · Cited by 214
Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.
Cairns, J., & Connolly, S. J. (1991) · Circulation · doi:10.1161/01.cir.84.2.469 · Cited by 207
Risk for systemic embolization of atrial fibrillation without mitral stenosis
Cabin, H. S., Clubb, K. S., Hall, C., Perlmutter, R. A., & Feinstein, A. R. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90323-s · Cited by 199
Antithrombotic Therapy in Valvular Heart Disease
Salem, D. N., Levine, H. J., Pauker, S. G., Eckman, M. H., & Daudelin, D. H. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.590s · Cited by 194
Thromboembolic complications in atrial fibrillation.
Petersen, P. (1990) · Stroke · doi:10.1161/01.str.21.1.4 · Cited by 193
Cardiac thrombosis and thromboembolism in chronic chagas' heart disease
de Oliveira, J. S. M., de Araújo, R. C., Navarro, M. A., & Muccillo, G. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90085-1 · Cited by 178
Antithrombotic Therapy in Atrial Fibrillation
Laupacis, A., Albers, G. W., DUNN, M. I., & Feinberg, W. M. (1992) · CHEST Journal · doi:10.1378/chest.102.4_supplement.426s · Cited by 169
Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation
Roy, D., Marchand, E., Gagné, P., Chabot, M., & Cartier, R. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90318-2 · Cited by 166
Management of cerebral embolism of cardiac origin.
Easton, J. D., & Sherman, D. G. (1980) · Stroke · doi:10.1161/01.str.11.5.433 · Cited by 161
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
Verstraete, M. (1990) · Drugs · doi:10.2165/00003495-199040040-00003 · Cited by 147
Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease.
Sage, J. I., & Uitert, R. L. V. (1983) · Stroke · doi:10.1161/01.str.14.4.537 · Cited by 147
Mitral valve disease, systemic embolism and anticoagulants
Fleming, H. A., & Bailey, S. M. (1971) · Postgraduate Medical Journal · doi:10.1136/pgmj.47.551.599 · Cited by 146
XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy.
Genton, E., Barnett, H. J. M., Fields, W. S., Gent, M., & Hoak, J. C. (1977) · Stroke · doi:10.1161/01.str.8.1.150 · Cited by 140
Arterial Embolism in Thyrotoxicosis With Atrial Fibrillation
Bar-Sela, S. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340090087019 · Cited by 138
Ischemic Cerebrovascular Complications of Pregnancy
Wiebers, D. O. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100092030 · Cited by 135
Cerebral infarction in young adults.
Grindal, A. B., Cohen, R. J., Saul, R. F., & Taylor, J. R. (1978) · Stroke · doi:10.1161/01.str.9.1.39 · Cited by 133
“The search for a cardiac embolic source is important since the value of anticoagulation in decreasing mortality and preventing recurrent embolism has been established.(14)'(16)”
Background
Antithrombotic treatment in atrial fibrillation
Lip, G. Y. H., & Boos, C. J. (2005) · Postgraduate Medical Journal · doi:10.1136/hrt.2005.066944 · Cited by 124
Cerebral embolism and mitral stenosis: survival with and without anticoagulants
Adams, G., Merrett, J. D., Hutchinson, W. M., & Pollock, A. M. (1974) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.37.4.378 · Cited by 122
“…of 172 patients reviewed by Keen and Leveaux (1958) showed an incidence of cerebral embolism of 20% but, in a much larger series (754 patients), Szekely (1964) found the overall incidence to be 9.6%0 onethird of emboli occurring within one month and two-thirds within a year of the onset of…”
BackgroundInfluential
Ten to fifteen year reassessment of the performance characteristics of the Starr-Edwards Model 6120 mitral valve prosthesis
Miller, D. C., Oyer, P. E., Stinson, E. B., Reitz, B. A., Jamieson, S. W., Baumgartner, W. A., Mitchell, R. S., & Shumway, N. E. (1983) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)38894-4 · Cited by 121
Clinical and neuroradiological analysis of thrombotic and embolic cerebral infarction.
Yamaguchi, T., Minematsu, K., Choki, J.-I., & Ikeda, M. (1984) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.48.50 · Cited by 118
Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Arima, H., Hart, R. G., Colman, S., Chalmers, J. P., Anderson, C. S., Rodgers, A., Woodward, M., MacMahon, S. W., & Neal, B. C. (2005) · Stroke · doi:10.1161/01.str.0000181115.59173.42 · Cited by 109
Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves
Chesebro, J. H., Adams, P. C., & Fuster, V. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80006-7 · Cited by 107
PROGNOSIS OF CEREBRAL EMBOLISM
Carter, A. B. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91473-x · Cited by 105
Coagulation activity is increased in the left atrium of patients with mitral stenosis
Yamamoto, K., Ikeda, U., Seino, Y., Mito, H., Fujikawa, H., Sekiguchi, H., & Shimada, K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00322-h · Cited by 102
Modern Management of Prosthetic Valve Anticoagulation
Tiede, D. J., Nishimura, R. A., Gastineau, D. A., Mullany, C. J., Orszulak, T. A., & Schaff, H. V. (1998) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64893-3 · Cited by 96
Cardiac valve prostheses in children without anticoagulation
Pass, H. I., Sade, R. M., Crawford, F. A., & Hohn, A. R. (1984) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)38409-0 · Cited by 87
Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care.
Kapral, M. K., & Silver, F. L. (1999) · PubMed · Cited by 87
Long-term results of DC reversion of atrial fibrillation.
Radford, M. D., & Evans, D. W. (1968) · Heart · doi:10.1136/hrt.30.1.91 · Cited by 87
“In patients with rheumatic heart disease the risk of embolism, while greater in those with atrial fibrillation (Szekely, 1964), is presumably decreased only”
Background
Physician Variation in Anticoagulating Patients With Atrial Fibrillation
Chang, H. J. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390130089012 · Cited by 86
Determinants of Increased Regional Left Atrial Coagulation Activity in Patients With Mitral Stenosis
Peverill, R. E., Harper, R. W., Gelman, J. S., Gan, T. E., Harris, G., & Smolich, J. J. (1996) · Circulation · doi:10.1161/01.cir.94.3.331 · Cited by 82
Incidence of systemic embolism before and after mitral valvotomy
Deverall, P. B., Olley, P. M., Smith, D. R., WATSON, D. A., & Whitaker, W. (1968) · Thorax · doi:10.1136/thx.23.5.530 · Cited by 82
“It is notable in Table VII that the duration of pre-operative study varied from four years (Ban-nister, 1960) to 20 years (Szekely, 1964).”
BackgroundResultInfluential
Predictors of left atrial spontaneous echo contrast and thrombi in patients with mitral stenosis and atrial fibrillation
González‐Torrecilla, E., Fernández, M. Á. G., David, E. P., Bermejo, J., Moreno, M., & Delcán, J. L. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01007-9 · Cited by 80
Treatment of progressing stroke.
Millikan, C. H., & MCDOWELL, F. H. (1981) · Stroke · doi:10.1161/01.str.12.4.397 · Cited by 78
DIRECT CURRENT COUNTERSHOCK COMPLICATIONS
Åberg, H. E., & Cullhed, I. (1968) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1968.tb10501.x · Cited by 75
Anticoagulant-related hemorrhage in acute cerebral embolism.
Shields, R. W., Laureno, R., Lachman, T., & Victor, M. (1984) · Stroke · doi:10.1161/01.str.15.3.426 · Cited by 74
Predictors of Cerebrovascular Events and Death Among Patients With Valvular Heart Disease
Petty, G. W., Khandheria, B. K., Whisnant, J. P., Sicks, J. D., O’Fallon, W. M., & Wiebers, D. O. (2000) · Stroke · doi:10.1161/01.str.31.11.2628 · Cited by 73
Mitral Valve Replacement with the Hancock Bioprosthesis: Five- to Ten-Year Follow-up
Borkon, A. M., McIntosh, C. L., Rueden, T. J. V., & Morrow, A. G. (1981) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)61019-3 · Cited by 73
Thromboembolic complications after mitral valve replacement with Hancock xenograft
Hetzer, R., Hill, J. D., Kerth, W. J., Ansbro, J. F., Adappa, M. G., Rodvien, R., Kamm, B., & Gerbode, F. L. A. (1978) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)41309-3 · Cited by 69
Making Decisions About Antithrombotic Therapy in Heart Disease: Decision Analytic and Costeffectiveness Issues
Eckman, M. H., Levine, H. J., Salem, D. N., & Pauker, S. G. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.699s · Cited by 68
Haemorrhagic and thromboembolic complications in patients with atrial fibrillation on anticoagulant prophylaxis
Lundström, T., & Rydén, L. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb00053.x · Cited by 63
New Evidence for Stroke Prevention
Straus, S. E., Majumdar, S. R., & McAlister, F. A. (2002) · Cited by 61
Nonvalvular atrial fibrillation as a cause of fatal massive cerebral infarction in the elderly.
Yamanouchi, H., Tomonaga, M., Shimada, H., Matsushita, S., Kuramoto, K., & TOYOKURA, Y. (1989) · Stroke · doi:10.1161/01.str.20.12.1653 · Cited by 61
Effectiveness of systematic screening for the detection of atrial fibrillation
Moran, P. S., Flattery, M. J., Teljeur, C., Ryan, M., & Smith, S. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009586.pub2 · Cited by 61
Antithrombotic Therapy in Valvular Heart Disease
Salem, D. N., Hartnett Daudelin, D., Levine, H. J., Pauker, S. G., Eckman, M. H., & Riff, J. (2001) · Chest · doi:10.1378/chest.119.1_suppl.207s · Cited by 60
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation
Karthikeyan, G., Connolly, S. J., Ntsekhe, M., Benz, A. P., Rangarajan, S., Lewis, G., Yun, Y., Sharma, S. K., Maklady, F., Elghamrawy, A., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.03.018 · Cited by 58
Open mitral valvotomy
Smith, W., Neutze, J. M., Barratt‐Boyes, B. G., Lowe, J. B., Upsdell, M. P., & Pemberton, J. R. (1981) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)39271-2 · Cited by 58
Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis
Li‐Saw‐Hee, F. L., Blann, A. D., Goldsmith, I. R. A., & Lip, G. Y. H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00060-0 · Cited by 57
Relation Between Mitral Regurgitation and Platelet Activation
Tse, H., Lau, C., & Cheng, G. Y.-M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00380-x · Cited by 56
The risk of thromboembolism and hemorrhage following mitral valve replacement
González-Lavin, L., Tandon, A. P., Chi, S., Blair, T. C., McFadden, P. M., Lewis, B., Daughters, G. T., & Ionescu, M. I. (1984) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)37383-0 · Cited by 55
Embolic complications of porcine heterograft cardiac valves
Jamieson, W. R. E., Janusz, M. T., Miyagishima, R. T., Munro, A. I., Tutassura, H., Gerein, A. N., Burr, L. H., & Allen, P. (1981) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)39498-x · Cited by 55
Influence of mitral regurgitation on left atrial thrombus and spontaneous echocardiographic contrast in patients with rheumatic mitral valve disease
Karatasakis, G., Gotsis, A., & Cokkinos, D. V. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80081-2 · Cited by 54
Diretrizes Brasileiras de Antiagregantes Plaquetários e Anticoagulantes em Cardiologia
Filho, A. M. L., Azmus, A., Soeiro, A., Quadros, A., Avezum, Á., Marques, A., Franci, A., Manica, A., Volschan, A., de Paola, A., et al. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2013s009 · Cited by 55
Systemic Embolism in Mitral Stenosis: Relation to the Size of the Left Atrial Appendix
Somerville, W., & Chambers, R. J. (1964) · BMJ · doi:10.1136/bmj.2.5418.1167 · Cited by 53
Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial
Pérez-Gómez, F., Salvador, A., Zumalde, J., Iriarte, J. A., Berjón, J., Alegría, E., Almerı́a, C., Bover, R., Herrera, D., & Fernández, C. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi667 · Cited by 50
“Total embolism and haemorrhagic strokes (rate) 10 (4.81) 6 (2.92) 4 (1.43) 2 (0.78) 6 (5.77) 4 (3.46) Death from heart failure 1 0 1 0 0 0 Severe bleeding (fatal) 5 (3) 5 (2) 3 (0) 4 (0) 5 (2) 3 ( 1 )”
Influential
Anticoagulation and Hemorrhagic Infarction in Cerebral Embolism Secondary to Rheumatic Heart Disease
Calandre, L., Ortega, J. F., & Bermejo, F. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050220046013 · Cited by 49
The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines
Macle, L., Cairns, J. A., Andrade, J. G., Mitchell, L. B., Nattel, S., Verma, A., Verma, A., Macle, L., Andrade, J. G., Atzema, C. L., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.06.005 · Cited by 47
Warfarin for Dilated Cardiomyopathy
Tsevat, J., Eckman, M. H., Mcnutt, R., & Pauker, S. G. (1989) · Medical Decision Making · doi:10.1177/0272989x8900900303 · Cited by 47
Atrial fibrillation: mechanism and clinical management
Hu, Z., Ding, L., & Yao, Y. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002906 · Cited by 45
“[43] Patients taking warfarin should undergo regular monitoring of the international normalized ratio (INR) and adjust the dosage to maintain it within the therapeutic target range of 2.0 to 3.0.”
Influential

Authors: Szekely, P.
Corresponding author: Szekely, P.
Venue: BMJ
Publisher: BMJ
Published: 1964-05-09
Volume: 1
Issue: 5392
Pages: 1209-1212
ISSN: 0007-1447 (ISSN-L)
0959-8138
1468-5833
DOI: 10.1136/bmj.1.5392.1209
PMC: PMC1814317
OpenAlex: W2089419646
Cited by: 325
References: 27
Citations by year: 2026: 1 · 2025: 1 · 2023: 5 · 2022: 1 · 2021: 7 · 2020: 9 · 2019: 3 · 2018: 6 · 2017: 5 · 2016: 7 · 2015: 6 · 2014: 10 · 2013: 10 · 2012: 5
FWCI: 9.44
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: BMJ (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: systemic embolism, thromboprophylaxis, rheumatic heart disease, thromboembolism, valvular heart disease
MeSH terms: Anticoagulants, Atrial Fibrillation, Embolism, Cardiac Surgical Procedures, Humans, Mitral Valve Stenosis, Preventive Medicine, Rheumatic Heart Disease, Statistics as Topic, Thoracic Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks